Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Breast Cancer Female”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01618136
What this trial is testing

An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors

Who this might be right for
Malignant Solid TumourOvarian CancerTriple Negative Breast Cancer+2 more
Eisai Limited 41
Early research (Phase 1)Ended earlyNCT03125200
What this trial is testing

Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) Expression

Who this might be right for
Breast CancerNon Small Cell Lung CancerGastroEsophageal Cancer+1 more
ADC Therapeutics S.A. 21
Early research (Phase 1)UnknownNCT05311618
What this trial is testing

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 71
Early research (Phase 1)Study completedNCT02947165
What this trial is testing

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

Who this might be right for
Breast CancerLung CancerHepatocellular Cancer+3 more
Novartis Pharmaceuticals 120
Testing effectiveness (Phase 2)Study completedNCT00305448
What this trial is testing

A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg

Who this might be right for
Advanced Breast CancerMetastatic Breast Cancer
AstraZeneca 143
Not applicableStudy completedNCT04098926
What this trial is testing

Highly Accelerated Dose-Integrated Radiotherapy in 5 Fractions in Breast Cancer

Who this might be right for
Breast CancerRadiotherapy
University Hospital, Ghent 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06531486
What this trial is testing

XS-02 Capsules in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorOvarian CancerBreast Cancer+1 more
NovaOnco Therapeutics Co., Ltd. 96
Testing effectiveness (Phase 2)Looking for participantsNCT07523529
What this trial is testing

Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors

Who this might be right for
Advanced UnresectableMetastatic
Beijing Biotech 72
Early research (Phase 1)Looking for participantsNCT06910657
What this trial is testing

IDOV-Immune for Advanced Solid Tumors

Who this might be right for
Colorectal CancerPancreatic CancerMelanoma+13 more
ViroMissile, Inc. 78
Testing effectiveness (Phase 2)Study completedNCT03394027
What this trial is testing

ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma

Who this might be right for
Triple Negative Breast CancerEndometrial CancerHormone Receptor Positive, HER2 Negative Breast Cancer
National Cancer Institute (NCI) 30
Not applicableStudy completedNCT00005956
What this trial is testing

Biological Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerGastric CancerOvarian Cancer
Duke University 3
Large-scale testing (Phase 3)Study completedNCT01237327
What this trial is testing

Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Pfizer 84
Early research (Phase 1)Study completedNCT03199586
What this trial is testing

Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies

Who this might be right for
Breast CancerPancreas CancerProstate Cancer+6 more
Novita Pharmaceuticals, Inc. 23
Testing effectiveness (Phase 2)Looking for participantsNCT07109726
What this trial is testing

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Who this might be right for
Breast CancerEndometrial CancerOvarian Cancer+5 more
Terremoto Biosciences Inc. 205
Not applicableStudy completedNCT01561443
What this trial is testing

LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer

Who this might be right for
Local Advanced or Metastatic Postmenopausal Breast Cancer
AstraZeneca 153
Testing effectiveness (Phase 2)Study completedNCT01151046
What this trial is testing

Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer

Who this might be right for
Her2 Negative Breast Cancer Patients
Merrimack Pharmaceuticals 118
Testing effectiveness (Phase 2)Active Not RecruitingNCT03678883
What this trial is testing

9-ING-41 in Patients With Advanced Cancers

Who this might be right for
CancerPancreatic CancerSarcoma+22 more
Actuate Therapeutics Inc. 350
Testing effectiveness (Phase 2)Study completedNCT02748213
What this trial is testing

Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 225
Early research (Phase 1)Study completedNCT03775850
What this trial is testing

EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

Who this might be right for
Colorectal Cancer MetastaticTriple Negative Breast CancerNon Small Cell Lung Cancer+4 more
Evelo Biosciences, Inc. 69
Early research (Phase 1)Active Not RecruitingNCT05215574
What this trial is testing

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 130
Next Page